What is the current stock price of Modalis Therapeutics Corporation (4883.T)?

As of the latest market data, Modalis Therapeutics Corporation (4883.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Modalis Therapeutics Corporation (4883.T) pay a dividend?

Based on current data, Modalis Therapeutics Corporation does not have a confirmed active dividend policy.

What is the market cap of Modalis Therapeutics Corporation?

The current market capitalization of Modalis Therapeutics Corporation (4883.T) is approximately unavailable.

4883.T

Modalis Therapeutics Corporation·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. The company was formerly known as EdiGENE Corporation and changed its name to Modalis Therapeutics Corporation in August 2019. Modalis Therapeutics Corporation was founded in 2016 and is headquartered in Tokyo, Japan.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

IPO Date

2020-08-03

Beta

0.11

Websitemodalistx.com↗